Gentry Leesa — Chief Clinical Officer
Insider trading activity for Gentry Leesa sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Clinical Officer
- Company: RenovoRx, Inc.
- Total insider trades: 1
- Total buy volume: $0
- Total sell volume: $0
- Last trade: Apr 7, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Apr 3, 2026 | Gentry Leesa | RNXT RenovoRx, Inc. | BUY | 128,550 | N/A |